This table outlines their typical use cases, advantages, drawbacks, and bioavailability
Medvidovic-Grubisic et al., 2017), stroke (Vukojevic et al., 2020), and spinal cord injury (Perovic et al., 2019))
Patients who are pregnant or breastfeeding, patients with active malignancy, patients with certain vascular conditions where angiogenesis is a concern, and patients on specific anticoagulants may not be candidates
For a 5mg vial of BPC-157 reconstituted with 2ml bacteriostatic water, the resulting concentration equals 2.5mg/ml or 2500mcg/ml
Memorial Sloan Kettering Cancer Center
The COA provides transparency on testing methods and results to support your research documentation and regulatory compliance